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Background: Recent investigations reported that osseointe-
gration of titanium implants can be significantly reinforced with
a nanostructure treated with anodic oxidation and heat treat-
ment. This experimental study investigates the effect of bis-
phosphonates on the nanotubular implant surface in rats.
Methods: Thirty-six titanium implants were divided into
three groups: 1) machine-turned (MT), 2) anodized and heat-
treated (AH), and 3) anodized and heat- and bisphosphonate-
treated (AHB) groups. The 36 implants were randomly placed
in both tibias of 18 male Wistar rats. After 2 and 4 weeks, the
levels of osseointegration of the implants were evaluated by
a removal torque test and microcomputerized tomography
(mCT). Peri-implant bone tissue on the extracted region was
examined for the expression of type I collagen and osteocal-
cin.
Results: The AHB group showed the highest removal torque
at 2 and 4 weeks (13.92 – 1.51 Ncm and 18.10 – 2.15 Ncm, re-
spectively) followed, in order, by the AH group (11.63 – 1.58
Ncm at 2 weeks and 14.80 – 2.34 Ncm at 4 weeks) and MT
group (4.30 – 0.76 Ncm at 2 weeks and 6.20 – 1.33 Ncm at
4 weeks) with statistically significant differences between the
MT and other two groups at both time points. mCT images also
revealed a denser appearance around implants in the AHB group
than in the other groups. Levels of type I collagen and osteocal-
cin expression were similar between the MT and AH groups;
however, the values were significantly higher in the AHB group
compared to the other groups, which were 220.85% – 71.09%
and 363.04% – 100.21%, respectively (P <0.05).
Conclusion: Within the limits of this experiment, it was con-
cluded that surface loading with bisphosphonates significantly
improved the degree of osseointegration of titanium implants
with a nanostructure. J Periodontol 2011;82:1035-1042.
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O
ver the past several decades,
titanium endosseous dental im-
plants were used as an alterna-
tive functional and esthetic restoration
in fully or partially edentulous patients.1
The predictable success of endosseous
dental implants is based on the primary
stability in the placement of dental im-
plants and the long-term rigid osseointe-
gration formed between the host bone
and implants. The characteristics of im-
plant surface are an essential factor to
consider when attempting to accelerate
osseointegration.
Titanium has been used extensively in
the field of dentistry and orthopedic sur-
gery because of its excellent mechanical
properties, higher degree of corrosion re-
sistance, low specific weight, and bio-
inertness. The bioinertness of titanium
results from the non-reactive titanium
dioxide (TiO2) layer, which is formed
spontaneously on the surface of titanium
in the body.2 This oxide layer helps pre-
vent the degradation of dental implants
in the human body. However, a prolonged
period of time is needed for osseointegra-
tion compared to bioactive materials.3
The latest clinical trends of dental im-
plants focus on methods to reduce the
overall treatment period. For this reason,
various surface-treatment methods to pro-
mote activity to the implant surface have
been proposed.4,5
In recent years, it was reported that the
formation of a titanium implant surface
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with a nanostructure could significantly reinforce the
osseointegration.6-12 An oxide layer of nanotube
titania with an ordered array, larger surface area,
and higher level of surface energy can be formed by
an anodic oxidation treatment on pure titanium or ti-
tanium-alloy surfaces.6-12 An anodic oxidation treat-
ment can form an oxide film with a homogeneous
thickness regardless of the surface shape of dental
implants. The thickness and characteristics of the
oxide layer can be adjusted by controlling processing
factors, such as voltage, current density, and electro-
lyte compositions.13 The surface of a nanostructure
can induce the migration of osteoblasts6-8 and mes-
enchymal stem cells9-11 and promote cell differenti-
ation and matrix synthesis, leading to accelerated
osseointegration. Because materials, such as hydroxy-
apatite and collagen, that form on an implant surface
during osseointegration have a nanosized struc-
ture, it is believed that a nanostructured surface
would be more favorable for osseointegration.12
The empty space of TiO2 nanotubes can be used as
a drug-delivery carrier (i.e., as an ideal drug-storage ma-
trix that can locally deliver drugs over a long period after
the implantation of dental implants). The local delivery of
drugs in dental implants aims to release the drugs solely
at the specific target with a relatively lower dose and
minimize the systemic drug toxicity.7,14 The drug im-
mobilization into a nanotube can be applied to various
chemicals, drugs, and biomolecules with sizes ranging
from small molecules to proteins, which can reduce
the inflammation and promote the osteoblastic func-
tions, thereby accelerating osseointegration.14,15
Bisphosphonates are drugs that are most commonly
prescribed to patients with osteoporosis. Bisphospho-
nates, which are one of the pyrophosphate analogs,
are composed of a P–C–P bond binding to hydroxyap-
atite (HA) crystals and two lateral chains. Of the lateral
chains, R1 is associated with the binding force to bone
mineral, and R2 plays a role in the antiosteoclastic effi-
cacy. If osteoclasts can absorb bisphosphonates during
bone resorption, the cytoskeleton within the osteoclasts
would be destroyed, resulting in a loss of the bone-
resorption function, which would eventually lead to an
apoptosis. Moreover, this phenomenon suppresses bone
resorption strongly by suppressing the differentiation
of osteoclasts and inhibiting the osteoclastic activity
by promoting osteoblasts.16 In vivo studies17-19 of den-
tal implants, whose surfaces were locally coated with
bisphosphonates, revealed larger amounts of bone for-
mation and a higher degree of bone-to-implant contact
in the early stage than on non-coated implants. There-
fore, the use of bisphosphonates on the surface of den-
tal implants was believed to promote osteogenesis and
to achieve faster osseointegration by suppressing the
activity of osteoclasts on the interface between the
bone tissue and dental implants.
Although positive effects of the nanotube structure
or bisphosphonates on the osseointegration of ti-
tanium implants were suggested,6-12,17-19 there is
a lack of up-to-date information regarding the effect
of bisphosphonates on the osseointegration of nano-
tubular implants. Therefore, the purpose of this ani-
mal study was to investigate additional effects of
bisphosphonates on the osseointegration of anodized
and heat-treated (AH) titanium surfaces.
MATERIALS AND METHODS
Preparation of Samples With a Nanotube TiO2
Layer, Heat, and Ibandronate Treatment
Thirty-six dental implants (2-mm diameter · 4-mm
length with five to six screw threads) were manufac-
tured from commercially pure grade IV titanium** in
a customizable manner. The dental implants were
rinsed ultrasonically in a solution containing acetone
and alcohol for 5 minutes each. All implants were
stored in a dryer at 50C for more than 24 hours before
the anodic oxidation treatment. To form TiO2 nano-
tubes, a titanium implant and platinum plate were
connected to the cathode and anode of a direct-cur-
rent power generator,†† respectively, and a pulse
power of 20 V and 20 mA/cm2 in 0.01-millisecond
cycles was applied for 60 minutes. The electrolyte
solutions were prepared by mixing glycerol with 20
weight % (wt%) H2O and 1 wt% NH4F. After the
anodic oxidation treatment, the sample surface was
rinsed ultrasonically for 1 minute. The samples were
stored in a dryer at 50C for 24 hours. Topographic
characteristics of the TiO2 nanotube structure were
observed under field emission–scanning electron mi-
croscopy (FE-SEM).‡‡ The structural stability of the
nanotube TiO2 layer and the removal of impurities
were achieved by placing the samples in a furnace
heated to 500C at a heating rate of 10C/minute
for 2 hours. For bisphosphonate treatment, one group
of the antiosteoporotic agents, ibandronate, was di-
luted in distilled water at a concentration of 1 mg/mL.
Each implant was immersed in the diluted drugs in
a 37C incubator for 24 hours to allow for the absorp-
tion of the drug.
Experimental Design and Implantation Procedure
The study was conducted in compliance with the prin-
ciples of the Helsinki Declaration of 1975, as revised
in 2000. Ethical clearance of the study was approved
by the Institutional Animal Care and Use Committee of
the Chonbuk National University Laboratory Animal
Center, Jeonju, South Korea.
For the experiment, both tibias of 18 male Wistar
rats (12 weeks old and weighing 200 to 225 g) were
** Kobe Steel, Tokyo, Japan.
†† Kwangduck, Bucheon, South Korea.
‡‡ S-800, Hitachi, Tokyo, Japan.
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used (total N = 36). Thirty-six dental implants were
divided into the following three groups: 1) machine-
turned (MT) (untreated titanium; n = 12), 2) AH (n =
12), and 3) anodized and heat- and bisphosphonate-
treated (AHB) (implants treated with ibandronate im-
mobilization after the anodic oxidation and thermal
treatment; n = 12).
The rats were allowed to acclimatize for 1 week
before the experimental study. The implant place-
ment surgery was performed under general anesthe-
sia using intramuscular administration of 1:1 mixture
of tiletamine and zolazepam (150 uL/200 g).§§ The
surgical site was shaved and disinfected with a beta-
dine scrub. An incision of 1.0 cm in length was made,
and the bone surface of the tibiae was surgically ex-
posed by blunt dissection. Under a profuse saline-so-
lution irrigation, bicortical implant beds were drilled at
a rotary speed £1,500 rpm. In total, 36 screw-shaped
titanium implants were placed using a self-tapping
process in the medial region of the bilateral tibia di-
aphysis in the 18 rats until the screw thread was com-
pletely introduced into the bone cortex. Resorbable
suturesii were used to approximate the surgical
wound. Postoperatively, amoxicillin (6 mg/kg) anti-
biotics and nabumetone (5 mg/kg) non-steroidal
anti-inflammatory drugs were orally administered
by dissolving them in the drinking water. Nine rats,
each at 2 and 4 weeks after implantation, were sacri-
ficed with an overdose of thiopental¶¶ (six implants
per time point, per group).
Removal Torque Analysis
The removal torque was measured at 2 and 4 weeks
post-implantation. Implant sites in the rat tibia were
surgically exposed via a sharp dissection to bone
and clinically examined after the careful removal of
overgrowing bone and soft tissues. An implant
removal mount was securely fastened and engaged
the external hex, which was connected to the torque
gauge with the insertion device. Removal torque tests
were performed on all implants (six implants per time
point, per surface) in the tibia using a digital torque
gauge.## After stabilizing the legs, the torque was in-
creased incrementally by slowly rotating the gauge
counterclockwise. The manual torquing continued
until a loosening of the implants was detected with
the peak torque value recorded when a rupture oc-
curred between the implant and bone. Peak torque
measurements were recorded by a single examiner
(T-SB) who was masked to the implant surface char-
acteristics. Mean torque measurements were calcu-
lated for each group.
Analysis of Bone-Formation Markers by
Western Blot
At 4 weeks, immediately after removal torque mea-
surements, bone tissue was collected in the areas
adjacent to the surface of the implants that were
removed. The tissue sample (six implants per sur-
face) was rinsed with saline, and the blood compo-
nents were removed. The tissue sample was ground
using a homogenizer after adding a protein lysis buffer
(20 mM Tris-HCl [pH 7.5], 137 mM NaCl, 10% glycerol,
1% Triton X-100, 1 mM Na3VO4, 1 mM phenylmethyl-
sulfonylfluoride, and 1· protease inhibitor cocktail).
After centrifugation at 12,000 · g for 15 minutes, su-
pernatants were used as cell extracts. Levels of type I
collagen and osteocalcin expression, which were
involved in the maturation and mineralization of oste-
ocytes, were confirmed by western blotting with ap-
propriate antibodies. Total proteins from the rat tibia
were separated with 10% sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis and transferred to a
polyvinylidene difluoride membrane.*** Membranes
were blocked with 5% non-fat skim milk (weight/vol-
ume) in Tris-buffered saline containing 0.5% Tween-
20 (volume/volume) (TTBS) at room temperature for
1 hour and then incubated overnight at 4C with rabbit
anti–type I collagen††† or antiosteocalcin‡‡‡ antibodies
diluted 1:1,000 in 5% non-fat skim milk in TTBS.
A horseradish peroxidase-conjugated antirabbit anti-
body§§§ was used as the secondary antibody (1:5,000
to 1:10,000 dilution in 5% non-fat skim milk in TTBS
for a 1-hour incubation at room temperature), and the




One day before sacrifice at 2 and 4 weeks, the exper-
imental rats were anesthetized, and implant areas
were scanned with a mCT scanner.¶¶¶ The voltage
and current of the x-ray tube were 100 kV and 100
mA, respectively, with 240 milliseconds of exposure
time. X-ray projections were obtained at 0.6 intervals
with a scanning angular rotation of 360. The image
pixel size was set for 18.104 mm. Among those micro-
images, we especially selected images in which
a screw line could be observed with the cross-section
following the long axis of the implant.
Statistical Analyses
The mean and SD of removal torque values and pro-
tein expression were calculated. Independent t tests
were used to compute 1) P values for differences in
removal torque values of each group between 2 and
§§ Zoletil 50, Virbac Laboratories, Carros, France.
ii 4.0 Polyglactin 910 (Vicryl), Ethicon, Livingston, U.K.
¶¶ Thiopental sodium, ChoongWae Pharma, Seoul, South Korea.
## 98109, Aikoh Engineering, Osaka, Japan.
*** Bio-Rad, Hercules, CA.
††† Santa Cruz Biotechnology, Santa Cruz, CA.
‡‡‡ Santa Cruz Biotechnology.
§§§ Santa Cruz Biotechnology.
iii ECL Plus, Amersham Biosciences, Piscataway, NJ.
¶¶¶ Skyscan1076, Skyscan, Aartselaar, Belgium.
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4 weeks, and 2) differences in the expression of
bone-formation markers (type I collagen and osteo-
calcin) between the MT group and other groups (AH
and AHB groups). The Tukey test was used to com-
pute P values for differences in removal torque
values among the three groups (MT, AH, and AHB).
P <0.05 was considered statistically significant. All
statistical analyses were carried out with computer
software.###
RESULTS
Surface Structure of the Nanotube TiO2 Layer of
Dental Implants
Figure 1shows FE-SEM images of the implant surface
after anodizing treatment. As shown in Figure 1C, the
surface consisted of a dense structure of independent,
self-organized nanotubes with mean diameters of
152.6 – 16.2 nm and 80.3 – 10.8 nm (Fig. 1C).
Cross-sectional lateral views of the layer were obtained
and showed that the diameters of nanotubes increased
from the superior to inferior direction with a mean
length of 506.7 – 25.0 nm (Fig. 1D). The nanotubes
that were sectioned longitudinally revealed the pres-
ence of multiple empty spaces (Fig. 1E).
Removal Torque Analysis
Table 1 presents the removal torque measured at 2
and 4 weeks after placing the dental implants. The re-
moval torque was higher at 4 weeks than at 2 weeks in
all groups, with the highest values in the AHB group at
both time points (Table 1). In addition, statistically
significant differences were found among the MT
and the other two groups at both time points, with
the MT being lowest (P <0.05) (Fig. 2).
Analysis of Bone Formation Markers
At 4 weeks postimplantation, the degree of mineraliza-
tionwas evaluated basedon the levels of type I collagen
and osteocalcin expression by western blot analysis.
Levels of type I collagen and osteocalcin expression
were similar in the bone tissues from the MT and AH
groups. In contrast, there were significantly higher
levels of type I collagen and osteocalcin expression in
the bone tissue from the AHB group compared to other
groups. Especially when compared with the MT group
(100%) the collagen expression level of the AHB group
was about two times higher (220.85% – 71.09%) and
the osteocalcin expression was about 3.6 times higher
(363.04% – 100.21%) than the MT group.
mCT Observation
Figure 4 shows mCT images of implants placed in rat
tibiae at 2 and 4 weeks after implantation. In the MT
group, only the outer area of threads was radiopaque,
with the inner area of threads being radiolucent on the
images. The AH group also exhibited a similar finding.
However, it was remarkable to see the AHB group
displaying radiopacity on the outer and inner areas
of threads. This implied that the intimate contacts
between the implant and surrounding bone in the
AHB group were the result of more bone deposition
on the implant surface. This feature was more remark-
able at 4 weeks than at 2 weeks, and the overall bone
density also increased at 4 weeks.
DISCUSSION
For the present study, the test titanium implants under-
went anodic oxidation to form a nanotube, followed by
a thermal treatment. Subsequently, ibandronate, one
of the bisphosphonates, was penetrated into the nano-
tube structure. The results of this study revealed that
the AHB implant group showed excellent biocompati-
bility and osseointegration that were superior to the MT
and AH groups. This superiority was well demonstrated
by the highest values of removal torque, protein ex-
pression, and analyses.
The removal torque analysis at 2 and 4 weeks re-
vealed the highest values found in the AHB group as
shown inTable 1 and Figure 2. Inaddition, inall groups,
the removal torque was relatively higher at 4 weeks
than at 2 weeks, with statistically significant differences
found in the MT and AHB groups. These outcomes cor-
respond well with results of other studies20,21 in which
bisphosphonate-treated titanium implants displayed
a higher mechanical fixation than uncoated titanium
implants. However, the experimental method used in
the previous studies was different from our method. Al-
though, in the present study, bisphosphonate treat-
ment was made through nanotubes on the implant
surface, the other studies used bisphosphonate treat-
ment on the surface of hydoxyapatite-coated titanium
implants. Furthermore, the results showed that the AH
and AHB groups had significantly higher values of
removal torque than did the MT group (Fig. 2). This
result showed that the rough surface with a TiO2-
nanotube layer might have contributed to the in-
creased values of removal torque in the AH and
AHB groups. The most-increased removal torque
values in the AHB group indicated a higher friction
force between the implant and surrounding bone, sug-
gesting that a higher degree of osseointegration ex-
isted in this type of implant.
mCT images taken at 2 and 4 weeks after placing den-
tal implants showed that the areas adjacent to the im-
plant screws were clearer and denser in the AHB
group than in the MT and AH groups (Fig. 4). This result
indicated that the degree of bone contact with the im-
plants was relatively higher in theAHB group, and more
bone was formed in the areas adjacent to the implant.
The mCT results and increased removal torque sug-
gested that the surface treated with bisphosphonates
### SPSS 12.0 for Windows, IBM, Chicago, IL.
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as well as the surface with a nanotube structure might
have induced an increase in bone formation, which
could have affected the physiochemical interactions
with adjacent bones.
The increased expression of bone formation markers
(Fig. 3) indirectly reflect the increased bone formation
in the AHB group. The degree of type I collagen and os-
teocalcin expression was highest in the AHB group and
with statistical significance. Type I collagen is one of
the most common collagenous bone proteins that
accounts for >90% of the bone matrix, which reflects
the bone formation. Osteocalcin is an osteogenic
marker that reflects the functions of osteoblasts in
association with the minerals contained in the bone
matrix. Hence, the highest levels of type I collagen
and osteocalcin expression in the AHB group indi-
cated that the activities of bone formation were the
greatest in the bisphosphonate-treated nanotubular
implants.
Positive effects of bisphosphonate treatment on the
implant surface in promoting osseointegration were
demonstrated in the literature.17-19,22 Meraw et al.17,18
examined the effects of alendronate on bone regenera-
tion after an alendronate treatment on the surface of
dental implants in an animal experimental model
using dogs.They17,18 reported that theuseofalendr-
onate increased the initial bone
formation and bone-to-implant
contact in the areas adjacent to
the implant.17,18 Zuffetti et al.19
performed a histopathologic
examination on bisphospho-
nate-treated implants 2 months
post-implantation in humans
andshowed that thebonedensity
and degree of bone-to-implant
contact were higher in bisphos-
phonate-treated implants than
in control implants. Further-
more, in a recent report,22 bis-
phosphonate-treated implants
were placed in the maxilla of
five patients using a two-stage
surgical procedure, and the im-
plant stability quotient (ISQ) was
measured at stage-I implant
surgery and after 6 months. The
results revealed that the largest
improvements in the ISQ level
of all implants were found for bis-
phosphonate-treated implants.
There isstill somecontroversy
regarding the mechanisms by
which TiO2 nanotubes are for-
med by anodic oxidation. The
formation of nanotubes has been
suggested to originate from the
electrochemical growth of an
oxide layer and the dissolution
Figure 1.
The morphology of the TiO2 nanotubes observed under FE-SEM. A) Surface of anodic, oxidized,
nanotubular implant of screw type. B) b = magnification of point a. C) Magnification of point b. D) Lateral
view. E) Internal structure. (Original magnification: A, ·70; B, ·5,000; C and D, ·100,000; E, ·250,000.)
Table 1.
Removal Torque Values at 2 and 4 Weeks (six implants per time point per surface)
Removal Torque MT Group* AH Group AHB Group*
2 weeks (Ncm; mean – SD) 4.30 – 0.76 11.63 – 1.58 13.92 – 1.51
4 weeks (Ncm; mean – SD) 6.20 – 1.33 14.80 – 2.34 18.10 – 2.15
* MT and AHB groups showed significant differences between the 2- and 4-week time points (P <0.05; independent t test).
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ofmetaloxidebyfluoride ions.23 In thisstudy, theanodic
oxidation was performed at 20 V and 20 mA/cm2 in
a glycerol solution containing 1 wt% NH4F and 20 wt%
H2O. Accordingly, in the early stage, an oxide layer
was formed over the surface because of the electro-
chemical oxidation. Subsequently, the oxide layer that
formed in the early stage dissolved, followed by the for-
mation of a self-organized TiO2 nanotube layer after 1
hour of anodic oxidation.
The empty space within the TiO2 nanotube can be
used as a drug-delivery carrier that can reduce the
inflammation or accelerate osseointegration by
promoting osteoblastic functions as well as by sup-
pressing osteoclast activities. According to Yao and
Webster,14 penicillin loaded into the anodized tita-
niumwithananotubestructureusingacoprecipitation
method in vitro was released over a 3-week period via
first-order kinetics. Compared to the untreated or an-
odized titanium, the level of bone-cell adhesion was
further increased.14 In addition, according to Bae
et al.,15 after loading the immobilized recombinant
human bone morphogenetic protein 2 in vitro, the
drugs were released gradually from the anodized
titanium with a nanotube structure over a 3-week pe-
riod. The activity of osteoblasts was relatively higher
than that observed on the non-
anodized titanium samples.15
Our previous in vitro study on
the release mechanism of
ibandronate also revealed that
the drug deposition and re-
lease activity were considerably
improved with the nanotube
structure (unpublished data).
In the present study, the con-
trolled release of bisphospho-
nates might have continuously
promoted the osseointegration
of the nanotube implants during
the healing period as demon-
strated by the higher mean
removal torque values in the
AHB group than in the MT and
AH groups.
Bisphosphonates are known
to have a strong affinity to cal-
cium and HA, which have a
great impact on the bone me-
tabolism by binding to the bone
tissue. Currently, bisphospho-
nates are used to treat bone
metabolic diseases, such as
osteoporosis, Paget disease,
multiple myeloma, and solid
tumors associated with the
bone metabolism. Reddy et al.24
and Weinreb et al.25 investigated the effects of bis-
phosphonates in animal models in which alveolar bone
resorption was induced by experimental periodontitis.
In the studies,24,25 it was shown that the systemic ad-
ministration of alendronate showed a positive effect in
Figure 2.
Comparison of removal torque values among groups. *Statistically
significant differences between the MT group and AH and AHB groups at
2 and 4 weeks (P <0.05; Tukey test).
Figure 3.
Expression of type I collagen and osteocalcin in extracted peri-implant tissues at 4 weeks. A) Level of type
I collagen demonstrated by the level of actin. B) Histogram representing the levels of type I collagen
protein relative to that of the MT group. C) Level of osteocalcin demonstrated by the level of actin. D)
Histogram representing the levels of osteocalcin protein relative to that of the MT group. *Significantly
higher level of type I collagen and osteocalcin expression in the bone tissue from the AHB group (P <0.05;
independent t test).
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reducing bone loss and increasing bone density. In
other studies,26,27 dental implants were placed with
or without a subcutaneous injection of alendronate
in rats in which osteoporosis was induced by a bilateral
ovariectomy. Removal torque values were signifi-
cantly higher in the alendronate-treated group than
in the other group that had undergone an ovariectomy
only. The results of the studies26,27 suggested that
systemic bisphosphonate administration might have
improved the osseointegration of titanium implants
placed in osteoporotic bone.
The systemic use of bisphosphonates has been
cautioned because of some side effects, such as esoph-
agitis, gastric ulcers, and osteonecrosis of the jaw
(ONJ).28-31 In particular, ONJ may occur after a tooth
extraction (or a treatment involving the dento-alveolar
structure) in a patient who received a systemic admin-
istration of bisphosphonates. ONJ was first reported
in 2003,28 but the precise mechanism is unclear. Ac-
cording to Marx et al.,29 the occurrence of ONJ might
be associated with an impairment of bone remodeling
and regeneration and the insufficient blood supply in
patients given bisphosphonates. More than 90% of re-
ported cases were described in cancer patients who re-
ceived an intravenous injection of bisphosphonate at
higher doses. In these cases, the incidence was asso-
ciated with the dose and treatment period. According
to the latest research,30,31 only the use of a high dose
of bisphosphonates was associated with the occur-
rence of ONJ in cancer patients. However, it was re-
ported that the use of a lower bisphosphonate dose
might have almost no rela-
tionship with the occurrence
of ONJ in patients with osteo-
porosis.30,31 Therefore, it was
suggested that the local use
of bisphosphonates in dental
implants may not be contrain-
dicated.30,31
CONCLUSIONS
In this in vivo, non-human ex-
periment, the removal torque,
bone density, and degree of
bone-formation marker ex-
pression increased after an
ibandronate treatment of an
anodized implant with a nano-
tube structure. These results
suggested that this surface
treatment increased the bio-
compatibility of the implant
surface, promoted the forma-
tion of the adjacent bone, and
accelerated osseointegration.
Additional studies, including
long-term clinical trials and histologic and histomor-
phometric analyses, are required to confirm the results
of the present study.
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